GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
type: MedicalStudy
description: Phase I Study of GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
status: RECRUITING
study design: INTERVENTIONAL
phase: PHASE1
start date: 2021-12-08
end date: 2027-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05003895
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Cancer Institute (NCI)
study subject: Hepatocellular Carcinoma
study subject: Hepatocellular Cancer
study subject: Metastatic Hepatocellular Carcinoma
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: RECRUITING
keywords: Hepatocellular Carcinoma
keywords: Hepatocellular Cancer
keywords: Metastatic Hepatocellular Carcinoma

AI Analytics
type: Organization